Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peng Xiang

Showing results (581-590 of 663) with videos related to

Pageof 67
Sort By:
Theranostics|May 1, 2019
Characterization and Therapeutic Application of Mesenchymal Stem Cells with Neuromesodermal Origin from Human Pluripotent Stem CellsHuiyan Wang, Dairui Li, Zhichen Zhai, et al.
Ebiomedicine|February 13, 2025
Dynamic forecasting module for chronic graft-versus-host disease progression based on a disease-associated subpopulation of B cells: a multicenter prospective studyYuanchen Ma, Jieying Chen, Zhiping Fan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 14, 2024
A phase III, randomized, controlled noninferiority trial to study the efficacy and safety of imipenem/cilastatin/relebactam (IMI/REL) vs piperacillin/tazobactam (PIP/TAZ) in patients with hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP)Junjie Li, Feng Wei, Peng Xiang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 3, 2024
Ex vivo-generated human CD1c<sup>+</sup> regulatory B cells by a chemically defined system suppress immune responses and alleviate graft-versus-host diseaseYingying Bao, Jialing Liu, Zhishan Li, et al.
Hepatology (Baltimore, Md.)|December 10, 2024
Distinct immune microenvironment of venous tumor thrombus in hepatocellular carcinoma at single-cell resolutionKai-Qian Zhou, Yu-Chen Zhong, Min-Fang Song, et al.
Cell Death and Differentiation|June 18, 2025
Endothelial cells-derived SEMA3G suppresses glioblastoma stem cells by inducing c-Myc degradationPeng-Xiang Min, Li-Li Feng, Yi-Xuan Zhang, et al.
Cancer Medicine|October 1, 2019
Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score-matched survival analysisYang Gao, Peng-Xiang Wang, Jian-Wen Cheng, et al.
Cell Reports|February 12, 2023
Durability of neutralization against Omicron subvariants after vaccination and breakthrough infectionKa-Li Zhu, Xiao-Lin Jiang, Bing-Dong Zhan, et al.
Cell Proliferation|November 4, 2020
General requirements for stem cellsJie Hao, Aijin Ma, Lei Wang, et al.
Protein & Cell|March 17, 2023
A single-nucleus transcriptomic atlas of primate testicular aging reveals exhaustion of the spermatogonial stem cell reservoir and loss of Sertoli cell homeostasisDaoyuan Huang, Yuesheng Zuo, Chen Zhang, et al.
Pageof 67

Showing results (581-590 of 663) with videos related to

Sort By:
Pageof 67
Theranostics|May 1, 2019
Characterization and Therapeutic Application of Mesenchymal Stem Cells with Neuromesodermal Origin from Human Pluripotent Stem CellsHuiyan Wang, Dairui Li, Zhichen Zhai, et al.
Ebiomedicine|February 13, 2025
Dynamic forecasting module for chronic graft-versus-host disease progression based on a disease-associated subpopulation of B cells: a multicenter prospective studyYuanchen Ma, Jieying Chen, Zhiping Fan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 14, 2024
A phase III, randomized, controlled noninferiority trial to study the efficacy and safety of imipenem/cilastatin/relebactam (IMI/REL) vs piperacillin/tazobactam (PIP/TAZ) in patients with hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP)Junjie Li, Feng Wei, Peng Xiang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 3, 2024
Ex vivo-generated human CD1c<sup>+</sup> regulatory B cells by a chemically defined system suppress immune responses and alleviate graft-versus-host diseaseYingying Bao, Jialing Liu, Zhishan Li, et al.
Hepatology (Baltimore, Md.)|December 10, 2024
Distinct immune microenvironment of venous tumor thrombus in hepatocellular carcinoma at single-cell resolutionKai-Qian Zhou, Yu-Chen Zhong, Min-Fang Song, et al.
Cell Death and Differentiation|June 18, 2025
Endothelial cells-derived SEMA3G suppresses glioblastoma stem cells by inducing c-Myc degradationPeng-Xiang Min, Li-Li Feng, Yi-Xuan Zhang, et al.
Cancer Medicine|October 1, 2019
Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score-matched survival analysisYang Gao, Peng-Xiang Wang, Jian-Wen Cheng, et al.
Cell Reports|February 12, 2023
Durability of neutralization against Omicron subvariants after vaccination and breakthrough infectionKa-Li Zhu, Xiao-Lin Jiang, Bing-Dong Zhan, et al.
Cell Proliferation|November 4, 2020
General requirements for stem cellsJie Hao, Aijin Ma, Lei Wang, et al.
Protein & Cell|March 17, 2023
A single-nucleus transcriptomic atlas of primate testicular aging reveals exhaustion of the spermatogonial stem cell reservoir and loss of Sertoli cell homeostasisDaoyuan Huang, Yuesheng Zuo, Chen Zhang, et al.
Pageof 67